全文获取类型
收费全文 | 88篇 |
免费 | 7篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 1篇 |
妇产科学 | 2篇 |
基础医学 | 1篇 |
临床医学 | 16篇 |
内科学 | 3篇 |
皮肤病学 | 1篇 |
神经病学 | 5篇 |
特种医学 | 1篇 |
外科学 | 7篇 |
综合类 | 28篇 |
预防医学 | 17篇 |
药学 | 7篇 |
中国医学 | 5篇 |
出版年
2023年 | 1篇 |
2022年 | 3篇 |
2021年 | 3篇 |
2020年 | 9篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2016年 | 1篇 |
2015年 | 4篇 |
2014年 | 2篇 |
2013年 | 6篇 |
2012年 | 5篇 |
2011年 | 7篇 |
2010年 | 6篇 |
2009年 | 6篇 |
2008年 | 7篇 |
2007年 | 6篇 |
2006年 | 1篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2003年 | 1篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 1篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1995年 | 2篇 |
1987年 | 2篇 |
排序方式: 共有95条查询结果,搜索用时 328 毫秒
21.
目的:比较替诺福韦酯(TDF)和恩替卡韦(ETV)治疗老年慢性乙型肝炎(CHB)患者的临床疗效及其对致炎细胞因子的调节作用,为其临床应用提供依据。方法:选取老年CHB患者93例,随机分为TDF组48例和ETV组45例,分别服用TDF (300mg/次,每天1次)和ETV (0.5mg/次,每天1次),连续观察48周。检测治疗前及治疗后4、12、24、36和48周时患者血清中HBV-DNA、丙氨酸氨基转移酶(ALT)、肿瘤坏死因子α(TNF-α)和白细胞介素10(IL-10)水平,检验ALT复常率、HBV-DNA阴转率和HBeAg阴转率。结果:与治疗前比较,治疗后2组患者血清中HBV-DNA和ALT水平均明显降低(P<0.05),治疗4和12周时TDF组患者血清中HBV-DNA和ALT水平明显低于ETV组(P<0.05)。与治疗前比较,治疗后2组患者血清中TNF-α和IL-10水平均明显下降,治疗12周时开始2组患者血清TNF-α和IL-10水平差异均有统计学意义(P<0.05)。治疗后,2组患者ALT复常率逐渐升高,治疗4和12周时TDF组患者ALT复常率明显高于ETV组(P<0.05)。治疗4周时2组患者均出现完全病毒学应答,HBV-DNA阴转率逐渐升高,治疗4、12和24周时,TDF组患者HBV-DNA阴转率明显高于ETV组(P<0.05)。TDF组患者于12周开始出现HBeAg阴转,早于ETV组;ETV组患者于24周出现HBeAg阴转,2组患者HBeAg阴转率比较差异无统计学意义(P>0.05)。结论:TDF和ETV均可用于治疗老年CHB,TDF抗病毒作用起效早,肝功能恢复快,炎症反应轻,是临床治疗的理想抗病毒药物。 相似文献
22.
A redox-neutral synthesis of dibenzo[b,d]pyran-6-ones from aryl ketone O-acetyl oximes and quinones has been realized via Rh(iii)-catalyzed cascade C–H activation annulation. A possible Rh(iii)–Rh(v)–Rh(iii) mechanism involving an unprecedented β-C elimination step was proposed.A novel procedure for the synthesis of dibenzo[b,d]pyran-6-ones via Rh(iii)-catalyzed C–H activation and C–C bond cleavage is described.The dibenzo[b,d]pyran-6-one is one of the most important structural motifs widely present in natural products with pharmacological relevance,1 such as gut microbiota metabolites urolithins (1–4) that show anti-inflammatory, antiglycative and neuroprotective effects,2–4 and the extracts of an endophytic fungus Cephalosporium acremonium IFB-E007 (5–7) that have pronounced anticancer activities.5 In addition, the related heterocyclic structure benzo[d]naphtho[1,2-b]pyran-6-one is found in some bactericidal and antitumor natural products including gilvocarcins6,7 (8–10) chrysomycins8,9 (11–13), etc. (Fig. 1). Therefore, a number of approaches to access dibenzo[b,d]pyran-6-ones have been developed via the intra- or inter-molecular biaryl formation as the key step.10 However, many of these methodologies require multi-step reactions, and the development of new efficient synthetic methods, especially those easy one-step reactions that are still of great interest.Open in a separate windowFig. 1Selected representative natural products.In the past decade, transition-metal-catalyzed C–H bond activation has proven to be a powerful tool in organic syntheses11 and several methods for the synthesis of dibenzo[b,d]pyran-6-ones via C–H activation have been reported.12 Actually, in 2015, our group reported Rh(iii)-catalyzed synthesis of dibenzo[b,d]pyran-6-ones from N-methoxybenzamides and quinones through C–H activation annulation.13 Interestingly, we obtained the same products using aryl ketone O-acetyl oximes as substrates to react with quinones under Rh(iii)-catalyzed conditions in this work. Rh(iii)-catalyzed C–H activation using ketoximes as substrates has been developed for synthesis of various substituted heterocycles.14 Compared to the previous reports, this reaction undergoes a novel mechanism involving an unexpected C–C bond cleavage, which is attractive. Moreover, our study demonstrated that solvent is vital to these reactions. In 2018, we reported Rh(iii)-catalyzed annulation of aryl ketone O-acetyl oximes with quinones to synthesize 6H-benzo[c]chromenes with acetone as a co-solvent.15 Herein, we described Rh(iii)-catalyzed synthesis of dibenzo[b,d]pyran-6-ones using the same substrates without acetone (Scheme 1).Open in a separate windowScheme 1Rh(iii)-catalyzed divergent C–H activation annulation with quinones.Initially, the reaction of acetophenone O-acetyl oxime 1a with benzoquinone 2a was employed to optimize the reaction conditions ( Entry Additive Solvent Temp °C Yieldb (%) 1 PivOH MeOH 50 12 2 PivOH MeOH 70 20 3 PivOH MeOH 90 36 4 PivOH MeOH 110 43 5 PivOH EtOH 110 26 6 PivOH DMF 110 37 7 PivOH THF 110 16 8 PivOH HFIP 110 0 9 PivOH Acetone 110 Trace 10 HOAc MeOH 110 Trace 11 Benzoic acid MeOH 110 50 12c Benzoic acid MeOH 110 70 13d Benzoic acid MeOH 110 63